Investing.com -- Mustang Bio Inc (NASDAQ: MBIO) stock surged over 78% after the U.S. Food and Drug Administration granted orphan drug designation to its MB-101 treatment for recurrent diffuse and ...

Tividenofusp alfa is a novel central nervous system-penetrant enzyme replacement therapy designed to address the neurological manifestations of MPS II by delivering IDS into the brain and body.

In addition to finding these dyes in brightly colored processed foods, the researchers also found them in more muted foods ...

The lawsuit argues that the HHS secretary’s withdrawal of public vaccine advice reduces access to vaccines for some people.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The medications still amount to around $500 per month for those without insurance—out of reach for many patients. And even ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr., who is making strides in his war against synthetic food dyes, ...

Sunscreen is not bad for your skin, but some formulations can cause issues for people with acne or allergy-prone skin, or who ...

Publix has had to manage several recalls involving both meat and non-meat products since the start of the year.

Mustang Bio shares more than quadrupled, to $5.23, after the company on Monday said the Food and Drug Administration granted orphan drug designation to Mustang for MB-101 for the treatment of ...